Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Neoplasms. Found 223 abstracts

no pagination
Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017 Oct 24;117(11):1583-91.   PMCID: PMC5729447
Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol. 2017 Jul;3(7):961-8.   PMCID: PMC5557289
Nieborowska-Skorska M, Maifrede S, Dasgupta Y, Sullivan K, Flis S, Le BV, Solecka M, Belyaeva EA, Kubovcakova L, Nawrocki M, Kirschner M, Zhao H, Prchal JT, Piwocka K, Moliterno AR, Wasik M, Koschmieder S, Green TR, Skoda RC, Skorski T. Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms. Blood. 2017 Dec 28;130(26):2848-59.   PMCID: PMC5746670
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.
Alexander J, Cukierman E. Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions. Current opinion in cell biology. 2016 Oct;42:80-93.   PMCID: PMC5064819
Bober SL, Reese JB, Barbera L, Bradford A, Carpenter KM, Goldfarb S, Carter J. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Current opinion in supportive and palliative care. 2016 Mar;10(1):44-54.   PMCID: PMC4984532
Meropol NJ, Wong YN, Albrecht T, Manne S, Miller SM, Flamm AL, Benson AB, Buzaglo J, Collins M, Egleston B, Fleisher L, Katz M, Kinzy TG, Liu TM, Margevicius S, Miller DM, Poole D, Roach N, Ross E, Schluchter MD. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials. J Clin Oncol. 2016 Feb 10;34(5):469-78.   PMCID: PMC4872012
Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: US-Blacks, Haitians, and Jamaicans. Cancer control : journal of the Moffitt Cancer Center. 2016 Oct;23(4):347-58.   PMCID: PMC5321133
Wong YN, Schluchter MD, Albrecht TL, Benson AB, Buzaglo J, Collins M, Flamm AL, Fleisher L, Katz M, Kinzy TG, Liu TM, Manne S, Margevicius S, Miller DM, Miller SM, Poole D, Raivitch S, Roach N, Ross E, Meropol NJ. Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. J Clin Oncol. 2016 Feb 10;34(5):479-87.   PMCID: PMC4872013
Banydeen R, Rose AM, Martin D, Aiken W, Alexis C, Andall-Brereton G, Ashing K, Avery JG, Avery P, Deloumeaux J, Ekomaye N, Gabriel O, Hassell T, Hughes L, Hutton M, Jyoti SK, Layne P, Luce D, Patrick A, Prussia P, Smith-Ravin J, Veronique-Baudin J, Blackman E, Roach V, Ragin C. Advancing Cancer Control Through Research and Cancer Registry Collaborations in the Caribbean. Cancer control : journal of the Moffitt Cancer Center. 2015 Oct;22(4):520-30.   PMCID: 4743663
Bradbury AR, Patrick-Miller L, Long J, Powers J, Stopfer J, Forman A, Rybak C, Mattie K, Brandt A, Chambers R, Chung WK, Churpek J, Daly MB, Digiovanni L, Farengo-Clark D, Fetzer D, Ganschow P, Grana G, Gulden C, Hall M, Kohler L, Maxwell K, Merrill S, Montgomery S, Mueller R, Nielsen S, Olopade O, Rainey K, Seelaus C, Nathanson KL, Domchek SM. Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genetics in Medicine. 2015 Jun;17(6):485-92.   PMCID: 4983405
Brusilovsky M, Radinsky O, Cohen L, Yossef R, Shemesh A, Braiman A, Mandelboim O, Campbell KS, Porgador A. Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44. Eur J Immunol. 2015 Apr;45(4):1180-91.   PMCID: PMC4415513
Culnan E, Kloss JD, Darlow S, Heckman CJ. Associations between seasonal sleep change and indoor tanning. Psychological Reports. 2015 Apr;116(2):523-33.
Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015 Dec;35 Suppl:S25-54.   PMCID: PMC4898971
Meng MB, Zaorsky NG, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W. Pericytes: a double-edged sword in cancer therapy. Future Oncol. 2015 Jan;11(1):169-79.
Olszanski AJ. Principles of immunotherapy. J Natl Compr Canc Netw. 2015 May;13(5 Suppl):670-2.
Peethambaram PP, Hartmann LC, Jonker DJ, de Jonge M, Plummer ER, Martin L, Konner J, Marshall J, Goss GD, Teslenko V, Clemens PL, Cohen LJ, Ahlers CM, Alland L. A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors. Invest New Drugs. 2015 Apr;33(2):321-31.
Prudnikova TY, Rawat SJ, Chernoff J. Molecular Pathways: Targeting the Kinase Effectors of RHO-Family GTPases. Clinical Cancer Research. 2015 Jan;21(1):24-9.   PMCID: 4286478
Rapoport N, Gupta R, Kim YS, O'Neill BE. Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging. J Control Release. 2015 May 28;206:153-60.
Rixe O, Puzanov I, LoRusso PM, Cohen RB, Morris JC, Olowokure OO, Yin JY, Doroumian S, Shen L, Olszanski AJ. Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. Anti-Cancer Drugs. 2015 Aug;26(7):785-92.   PMCID: 4484664
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Neoplasms

Neoplasms Female therapy genetics drug therapy pathology Male methods drug effects Aged therapeutic use Middle Aged metabolism antagonists & inhibitors immunology administration & dosage Antineoplastic Agents epidemiology Patient Education as Topic pharmacokinetics United States Signal Transduction Surveys and Questionnaires Adult biosynthesis diagnosis Clinical Trials as Topic psychology Tumor Cell Line blood supply adverse effects Drug Dose-Response Relationship Neoplastic Stem Cells Molecular Targeted Therapy Pathologic Neovascularization Decision Making Maximum Tolerated Dose etiology Neoplasm Metastasis Syndecan-4 Monoclonal Antibodies Methylprednisolone Cognitive Science analogs & Calreticulin Genetic Testing African Continental Ancestry Group Epithelial-Mesenchymal Transition Cohort Studies Tumor Microenvironment derivatives Intravenous Infusions pericytes Psychological Sexual Dysfunctions Immune-related adverse events Innate Immunity Folic Acid Exercise Therapy Internet Workaholism Angiogenesis Inhibitors Melanoma NK cell activation Conflict (Psychology) Fatigue neovascularization Thrombopoietin Receptors Glucocorticoids Extracellular Matrix Disease Progression Dextroamphetamine NKp44 rho GTP-Binding Proteins Haiti Communication Drug Delivery Systems Optical Imaging Health Communication Fibroblasts Reproductive Health Carcinogenesis Self Efficacy anti-angiogenesis therapy DNA Repair Nanoparticle extravasation Nivolumab Cell Line neoplasms Genetic Heterogeneity mortality Binding Sites Physiological Processes [2540] CTLA-4 Antigen Attitudes Health Knowledge-Practice Heparan sulfate Piperazines Half-Life Taxoids Incidence Registries Nude Mice Survivors Phosphotransferases Follow-Up Studies Biological Models Intravital microscopy Paclitaxel Prospective Studies Decision Support Techniques Nanoparticles Platelet-Derived Growth Factor Drug Carriers adverse Nanodroplets Phthalazines Polymers Nanoparticle diffusion Thyroiditis Cell Cycle Proteins Myeloproliferative Disorders Cooperative Behavior Perfluorocarbon effects Heterografts Platelet-Derived Growth Factor beta Receptor Drug delivery Early Intervention (Education) Prognosis Case-Control Studies Phytogenic Antineoplastic Agents Cultured Tumor Cells Genetic Counseling Therapeutic targets Patient Participation Cancer-Associated Fibroblasts ethics Women's Health Serotonin Uptake Inhibitors Physiological Sexual Dysfunction Sleep Heparan Sulfate Proteoglycans Antineoplastic Combined Chemotherapy Protocols National Cancer Institute (US) Methylphenidate Natural products Immune regulation Cytokines indoor tanning sleep-skin cancer-risk factors Pyrazoles Cancer stem cells
Last updated on Friday, February 02, 2018